Hashmi Herbal Group To Explore Strategic Alternative For Health Business

Online, December 13, 2011 (Newswire.com) - Hashmi Herbal today announced that it is exploring strategic alternatives for its health care business. Based on its old business portfolio review to determine the optimal mix of business for maximizing core value of Hashmi Herbal Group. The company is considering options that may include, among others, a full or partial separation of each of these businesses from Hashmi herbal. Given the separate and distinct nature of healthcare products. Company may pursue a different strategic alternative for each business.

Herbal Medicine and Nutrition are strong businesses with attractive customer bases and solid fundamentals, but distinct enough from our core businesses that their value may be best maximized outside the company," said Dr. Hashmi, CEO, Hashmi Herbal. "In exploring these alternatives, we can determine what options will best drive their future growth opportunities and expansion.

Hashmi Herbal is a world leader in the discovery, development, manufacture and commercialization of herbal products, including diabetes, medicines, diagnosis, to prevent and treat disease. This business has operations in more than 10 countries, an extensive research and development network with major research centers and strong market positions across several geographic regions, including the United States, Europe, Africa and Middle East and Asia-Pacific.

Hashmi Herbal will continue to enhance the value of its Established Products business within the company. The herbal industry's fastest-growing markets are in the emerging markets, and within the emerging markets, the fastest-growing segment is off-patent medicines and their generic equivalents. Given these dynamics and the company's footprint and asset base, the company believes that the Established Products business is well positioned to capture the opportunities being created by the demographics and rising economic power within these markets. Also based on this portfolio review, the company believes that it can continue to enhance the value of its Consumer Healthcare business within Hashmi Herbal.

The actions we're announcing today are driven by the potential to create value for patients and enable Hashmi herbal to become a more focused organization, better positioned for future success," said Dr. Hashmi. "Ultimately, our decisions will continue to support our long-term strategy to allocate our resources, investments and people to the areas that best serve our patients and customers, and generate the best value for our shareholders."

At Hashmi Herbal Group, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known herbal products.